Florida Sues Pfizer Over COVID-19 Vaccine Safety and Efficacy Claims

Florida's Attorney General has filed a lawsuit against pharmaceutical giant Pfizer Inc. (PFE) and its CEO, Albert Bourla, accusing the company of making misleading claims about its COVID-19 vaccine. The legal action, filed in a Florida state court on Thursday, alleges violations of the state's consumer protection law.

Details of the Complaint

The lawsuit, brought forth by Attorney General James Uthmeier, alleges that Pfizer misrepresented the safety and effectiveness of its vaccine. According to the complaint, the company failed to adequately disclose potential risks, such as heart inflammation and other adverse events, while promoting the product as safe for consumers.

Florida's suit also claims Pfizer promoted the vaccine as a tool to protect others by preventing transmission, despite allegedly not having tested for this capability. The state further accuses the company of employing unfair market tactics to establish dominance, citing its more than $80 billion in vaccine sales and a subsequent price increase.

Key allegations in the lawsuit include:

Ad

• Misrepresenting vaccine safety by concealing potential adverse events.
• Falsely claiming the vaccine would prevent virus transmission.
• Engaging in unfair practices to dominate the market.
• Increasing the vaccine price nearly fourfold from approximately $30 to a range of $110 to $130 per dose in 2023.

Financial Penalties and Market Impact

The state is seeking a court order to halt the alleged conduct, along with significant financial penalties. Florida has requested fines of $10,000 per violation, which could increase to $15,000 for violations involving seniors or disabled individuals. The lawsuit also seeks the return of profits Pfizer earned as a result of the alleged misconduct.

Following the news, shares of Pfizer traded approximately 1% lower on Thursday. The lawsuit introduces new legal and financial risks for the company, which has faced scrutiny over its vaccine business following the peak of the pandemic.